Free Cash Flow

A new Swiss FinTech, Lubit, launches a prediction market for energy, aiming to replace big-money trading with skill-based crowd intelligence.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

Amid a record backlog and major program milestones, CEO Kathy Warden is set to detail the defense giant's strategy at Citi's upcoming tech and mobility event.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.

Financially robust and debt-free, Rail Vision is rapidly expanding its AI safety systems globally while a new quantum computing arm aims to redefine the future of rail.

With a new OTCQB listing, Pecoy Copper aims to unlock U.S. capital for its massive Peruvian project amid a looming global copper shortage.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

Amid a surging aerospace market, StandardAero's upcoming earnings report is highly anticipated after a year of record growth and strategic expansion.

The defense contractor signals a strategic shift after lost contracts and procurement delays slash its 2027 revenue outlook, even as profits beat expectations.

Terex declared a steady dividend, but the real story is its surging stock and a bold forecast, revealing deep confidence in its strategic direction.

With key leadership promotions, AscellaHealth aims to streamline the complex path from drug discovery to patient delivery for life sciences companies worldwide.

With 70M users worldwide, Breo is launching its ibreo brand in America, challenging the market with patented massagers and a 'quiet luxury' design.

The strategic sale by MPE Partners creates a dominant force in the MRO market, combining specialized power and propulsion expertise with a national service leader.

After a stellar 2025, Corpay is hitting the road for key investor conferences. Can it convince the market its impressive growth is just the beginning?

With $4.5M donated last year, MAC's iconic lipstick program has evolved from an AIDS crusade into a global force for racial, gender, and environmental justice.

After a stock plunge, Yext offers to buy back shares at a premium, signaling deep undervaluation and creating a critical choice for its investors.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

The Baltic real estate giant divests a key Latvian asset at a profit, unlocking millions in capital for new investments and signaling a hot logistics market.

Cloud communications firm RingCentral will join the S&P SmallCap 600, triggering investment shifts and highlighting tech's growing market influence.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.